Clinical Trials Logo

Filter by:
NCT ID: NCT05314374 Enrolling by invitation - Healthy Clinical Trials

Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype

Start date: May 12, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this research is to study the effect of the study drug (a conjugated bile acid dietary supplement) or placebo on cell function, hormones and body weight.

NCT ID: NCT05314088 Enrolling by invitation - Clinical trials for Stress, Psychological

Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV

RISE+
Start date: February 3, 2023
Phase: N/A
Study type: Interventional

This study will examine the mechanisms and efficacy of a resilience building intervention in older people living with HIV.

NCT ID: NCT05313321 Enrolling by invitation - Clinical trials for Primary Total Hip Arthroplasty

Survival of the Insignia Stem in Total Hip Arthroplasty

Start date: March 17, 2022
Phase:
Study type: Observational

The investigators primary objective of this study is to evaluate radiographic fit and fill of the Insignia stem and identify risk factors for aseptic failure. The investigators hypotheses being tested is: the newly designed Insignia stem demonstrates acceptable radiographic fit and fill by reviewing radiolucent lines <2mm.

NCT ID: NCT05312229 Enrolling by invitation - Homelessness Clinical Trials

Housing Transitions QUERI

Start date: October 1, 2021
Phase: Phase 1
Study type: Interventional

The VA Grant and Per Diem (GPD) case management aftercare program provides six months of case management for homeless-experienced Veterans undergoing housing transitions. This Partnered Implementation Initiative (PII) proposes to implement and evaluate Critical Time Intervention (CTI)-an evidence-based, structured, and time-limited case management practice-in 32 GPD case management aftercare sites across the nation.

NCT ID: NCT05308992 Enrolling by invitation - Condom Users Clinical Trials

User Preference Study of an Experimental HydroGlyde Male Condom Compared to a Commercial Latex Male Condom

Start date: March 1, 2022
Phase: Early Phase 1
Study type: Interventional

Latex condoms have long been available as contraceptive devices as well as an effective means of preventing the spread of sexually transmitted infections. However, lack of adequate lubrication leads to inconsistent and incorrect condom use. The latex HydroGlyde condom has a hydrophilic coating which maintains its lubricity when in contact with water. Improved lubrication during intercourse may lead to improved user satisfaction and increased condom use which would help prevent the spread of Sexually Transmitted Infections and unwanted pregnancies. The primary objective of this study is to evaluate the preference, performance (breakage, slippage), safety (adverse events) and acceptability of a HydroGlyde prototype condom compared to a commercial latex condom with silicone lubricant. A secondary objective of this study is to compare and evaluate various lubricant activation methods for reliability, usability, and user preference.

NCT ID: NCT05307432 Enrolling by invitation - Suicide Clinical Trials

Safety Planning Intervention Telehealth Service Model in Emergency Departments

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and implementation of a suicide prevention strategy delivered via telehealth in Emergency Departments. We will compare implementation of the Safety Planning Intervention plus follow-up calls (SPI+) delivered by Emergency Department (ED) staff to SPI+ delivered via ED referral to an off-site Suicide Prevention Consultation Center (SPCC).

NCT ID: NCT05305105 Enrolling by invitation - Clinical trials for Post-Treatment Lyme Disease

Effects of Psilocybin in Post-Treatment Lyme Disease

Start date: July 1, 2022
Phase: Phase 1
Study type: Interventional

This study will examine the effects of psilocybin on Lyme disease symptom burden and quality of life in people with Post-Treatment Lyme Disease (PTLD).

NCT ID: NCT05304767 Enrolling by invitation - Schizophrenia Clinical Trials

An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia

Start date: March 7, 2022
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multicenter, 52-week, outpatient, open-label extension (OLE) study to evaluate the long-term safety and tolerability of adjunctive KarXT in subjects with schizophrenia with an inadequate response to their current antipsychotic treatment who previously completed the treatment period (Visit 8/Day 42 ± 3) of ARISE Study (KAR-012). The primary objective of the study is to assess the long-term safety and tolerability of adjunctive KarXT (a fixed dose combination of xanomeline and trospium chloride twice daily [BID]) in subjects with schizophrenia.

NCT ID: NCT05304728 Enrolling by invitation - Severe Sepsis Clinical Trials

Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol

Start date: February 15, 2021
Phase:
Study type: Observational

This protocol will collect real-world data retrospectively from the electronic health record (EHR) as data obtained from the delivery of routine medical care to develop a machine learning (ML)-based Clinical Decision Support (CDS) system for severe sepsis prediction and detection.

NCT ID: NCT05303532 Enrolling by invitation - Cancer Clinical Trials

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab

ROSY-D
Start date: April 19, 2022
Phase: Phase 3
Study type: Interventional

The rationale of the ROSY-D study is to continue to provide study treatment for patients who have participated in a parent study with Durvalumab and who are continuing to derive clinical benefit from treatment at the end of such studies, as judged by the Investigator.